Results 111 to 120 of about 40,015 (285)
Apremilast in Japanese patients with palmoplantar pustulosis: A randomized, Phase 3 trial
In this Phase 3 trial of Japanese patients with moderate to severe PPP (NCT05174065), significantly more patients achieved PPPASI‐50 at Week 16 with apremilast versus placebo. Patient‐reported outcomes, including pruritus and pain/discomfort, also showed significantly greater decreases at Week 16 with apremilast versus placebo.
Tadashi Terui +15 more
wiley +1 more source
Think outside the box - atypical infections in chronic sinusitis. [PDF]
Dudde F, Henkel KO, Barbarewicz F.
europepmc +1 more source
ABSTRACT Introduction Medication‐Related Osteonecrosis of the Jaw (MRONJ) is a severe adverse effect of antiresorptive and antiangiogenic treatment, primarily in osteoporotic and oncologic patients. The disease is characterized by persistent jawbone necrosis that results in significant impairment of the quality of life of involved patients.
Omar Ghanaiem +2 more
wiley +1 more source
Invasive Fungal Sinusitis: Clinical Pathologic Characteristics of Acute vs. Chronic Infections [PDF]
Yasuhisa Kitagawa +2 more
openalex +1 more source
ABSTRACT Background Oroantral communication (OAC) and fistulas (OAF) are pathological openings between the maxillary sinus and the oral cavity. Traditional closure methods, such as buccal or palatal flaps, are effective but can cause postoperative discomfort and tissue loss.
Feras AlMofreh AlQahtani +3 more
wiley +1 more source
[Role of nasal microbiome in chronic sinusitis]. [PDF]
Linlin Wang +3 more
openalex +1 more source
The role of antibiotics in preventing surgical complications in periodontology and implant dentistry
Abstract Antibiotics are commonly prescribed in periodontal and implant surgeries, either before, during or after surgery, to prevent postoperative infection and reduce early implant failure. However, the potential benefits may be undermined by the risks of resistance and sensitization, thus requiring a strict indication for prescription.
Zhaozhao Chen +3 more
wiley +1 more source

